Basic Mercilon Information

• INN (International Nonproprietary Name): Desogestrel and Ethinyl Estradiol
• Brand Names Available In United Kingdom: Not specified
• ATC Code: G03AA11
• Forms & Dosages: Tablet; 21 active tablets of 0.15 mg desogestrel + 0.02 mg ethinyl estradiol, 2 inert tablets and 5 ethinyl estradiol-only tablets of 0.01 mg; oral once daily
• Manufacturers In United Kingdom: Teva, Amneal, Aurobindo, Zydus, Lupin (generics and international versions)
• Registration Status In United Kingdom: Not specified
• OTC / Rx Classification: Prescription (Rx only)

Latest Research Highlights (UK And EU 2022–2025)

What is the recent evidence saying about desogestrel and ethinyl oestradiol combinations in the UK and EU?

Recent UK and EU systematic reviews and post-authorisation assessments by regulators have continued to classify desogestrel/ethinyl oestradiol combinations as effective combined oral contraceptives.

Effectiveness under typical use is comparable to other combined oral contraceptive pills when taken correctly.

Safety signals remain consistent with the established oestrogen-containing pill class effects, notably venous thromboembolism risk, breakthrough bleeding and mood changes.

Large UK cohort and pharmacoepidemiology datasets have emphasised monitoring for VTE in higher-risk subgroups such as older age, raised BMI, smokers and those with a family history of thrombosis.

Real-world adherence studies note that biphasic 28-day packs featuring 21 active 0.15 mg desogestrel + 0.02 mg ethinyl oestradiol tablets, 2 inert tablets and 5 low-dose 0.01 mg ethinyl oestradiol tablets are moderately associated with spotting during early cycles.

These same adherence studies report reasonably good continuation at six months when users receive pharmacy counselling and practical adherence support.

Regulators including the Medicines and Healthcare products Regulatory Agency and the European Medicines Agency continue post-marketing surveillance and periodic safety reviews.

Clinicians should consult MHRA safety updates and EMA assessments as part of routine prescribing checks.

Clinical Effectiveness In The UK

How does desogestrel plus ethinyl oestradiol perform in everyday NHS practice?

Clinical effectiveness in NHS settings reflects trial efficacy but is modified by real-world adherence patterns.

The biphasic packs with 0.15 mg desogestrel and 0.02 mg ethinyl oestradiol active tablets plus low-dose and inert tablets deliver pregnancy prevention comparable to other combined oral contraceptives when taken correctly.

Typical-use failure rates mirror other combined pills because missed tablets remain the main driver of contraceptive failure.

NHS audits and community contraception clinics report the common challenges as missed pills, bleeding or spotting when initiating the pill, and subjective side effects that influence continuation.

Pharmacy-led adherence interventions such as pill reminders and blister-pack counselling increase continuation and reduce emergency contraception consultations.

• Adherence Interventions: Pill reminders and follow-up calls
• Adherence Interventions: Blister-pack counselling and simple written instructions
• Adherence Interventions: Pharmacy counselling on missed-pill actions and spotting management

Prescribers should align prescriptions with local formularies and flag contraindications in NHS records and e-prescription systems.

Indications And Expanded Uses (Mhra & NHS Context)

What is this pill licensed for and how is it used in UK practice?

The MHRA-aligned licensed indication is contraception.

In UK clinical practice some clinicians use combined desogestrel/ethinyl oestradiol pills off-label for cycle regulation, dysmenorrhoea or acne when clinically appropriate and documented.

Private clinics may prescribe for menstrual suppression or perimenstrual migraine prophylaxis only where benefits outweigh risks and no contraindications exist.

Absolute contraindications such as pregnancy, prior VTE, severe liver disease, uncontrolled hypertension, migraine with aura and smoking over 35 remain decisive for MHRA-guided prescribing.

On-Label Uses: Contraception, standard 28-day regimen; start Day 1 or Sunday start per pack instructions.

Off-Label Uses: Cycle regulation, dysmenorrhoea, acne or menstrual suppression with documented clinical justification and patient consent.

• Checklist For Documentation: Indication, informed consent, contraindication check, counselling provided, Yellow Card advice given

Always record the indication on NHS e-records and provide written patient information and Yellow Card reporting advice if adverse events occur.

Composition And Brand Landscape (UK/Eu Generics)

What is in the pack and what brands supply it in the UK and EU?

The INN is Desogestrel and Ethinyl Estradiol and the ATC code is G03AA11.

Typical packs follow the Mircette design with 21 active tablets of 0.15 mg desogestrel + 0.02 mg ethinyl estradiol, two inert tablets and five ethinyl estradiol-only tablets of 0.01 mg.

Although Mircette is discontinued in the USA, generic equivalents and similar biphasic packs are marketed by multinational manufacturers in the UK and EU.

Prescribers will typically encounter generics listed on local formularies and electronic prescribing systems, and should check the BNF and MHRA for licence variations.

Excipient considerations should be checked for known allergies and recorded when relevant.

Contraindications And Special Precautions

Who should not take desogestrel plus ethinyl oestradiol and what precautions matter in everyday life?

Absolute contraindications include pregnancy, history of thromboembolic events, severe hepatic disease or liver tumours, uncontrolled hypertension, migraine with aura, smoking over 35, known or suspected hormone-dependent malignancy, undiagnosed genital bleeding and hypersensitivity to components.

Relative risks requiring enhanced monitoring include controlled hypertension, diabetes with vascular disease, hyperlipidaemia, certain migraine patterns, obesity and recent immobilisation.

Practical precautions include advising against heavy alcohol consumption when starting a hormonal method because alcohol may mask adverse effects.

Patients should take care during prolonged immobility or long-haul flights and should report any unexpected symptoms such as calf pain or chest pain without delay.

Storage: store below 25°C in the original packaging and protect from moisture and light.

Clinicians and pharmacists should counsel patients about Yellow Card reporting for suspected adverse reactions.

Dosage Guidelines (NHS-Recommended Regimens)

How should the biphasic pack be taken and what are the common missed-pill rules?

Standard dosing is one tablet once daily at the same time for 28 days with no pill-free interval.

The pack design—21 active tablets of 0.15 mg desogestrel + 0.02 mg ethinyl oestradiol, two inert tablets and five ethinyl oestradiol-only tablets of 0.01 mg—aims to reduce withdrawal symptoms and maintain cycle control.

Initiation may be Day-1 start or a Sunday start according to pack instructions; if starting after Day 1 advise barrier contraception for seven days.

Missed-pill guidance in brief: one missed active tablet—take as soon as remembered which may mean taking two tablets in one day.

If more than one active tablet is missed follow pack instructions, consider emergency contraception if unprotected sex occurred in week 1 and use backup for seven days.

Special populations: use standard dosing for adolescents post-menarche and do not use in post-menopausal women.

Contraindicated in severe hepatic impairment and dose adjustments are not generally recommended for routine renal impairment.

Interactions Overview (Drugs, Food, Mhra Yellow Card Data)

Which medicines and products can affect the pill, and what do Yellow Card reports show?

Significant drug interactions include enzyme inducers such as rifampicin, rifabutin, some antiepileptics and certain HIV/HCV protease inhibitors which can reduce contraceptive efficacy.

St John’s wort is a herbal inducer that reduces plasma hormone levels and should be avoided with combined hormonal contraception.

Common antibiotics other than rifampicin are generally not proven to affect efficacy but advise caution and backup contraception if there is concern.

Food interactions are minimal and common drinks such as tea or coffee do not have clinically meaningful effects.

MHRA Yellow Card reports for desogestrel plus ethinyl oestradiol mirror class-wide events with reports of VTE, stroke and hepatic events; these are rare but clinically important.

Always check the BNF and local drug interaction tools when prescribing or dispensing combined hormonal contraception.

Cultural Perceptions And Patient Habits In The UK

How do UK patients find and use contraceptives and what influences their expectations?

Patients commonly consult GPs, sexual health clinics or community pharmacists for contraceptive advice.

Pharmacist counselling and NHS 111 or Patient.info guidance are trusted sources of information for many users.

Online forums such as Mumsnet and Reddit influence expectations regarding side effects, and conversations about spotting and mood changes are common.

Regional attitudes vary, with younger urban populations more likely to use online repeat prescription services and older or rural patients preferring face-to-face pharmacy advice.

Pharmacy chains including Boots, LloydsPharmacy and Superdrug increasingly offer private contraception services and online ordering, while prescriptions remain required.

NHS e-prescriptions and patient portals have normalised remote renewals, and clinicians should counter misinformation with evidence-based counselling.

• Common Patient Concerns: Spotting, mood changes, weight change and VTE risk
• Suggested Counselling Phrases: 'If you notice sudden calf pain or chest pain, seek urgent care' and 'Spotting is common in early cycles; contact us if it persists'

Availability And Pricing Patterns In The UK

Where can patients get desogestrel and ethinyl oestradiol in the UK and what will it cost?

Desogestrel plus ethinyl oestradiol generics appear on UK formularies and availability varies by supplier and local pharmacy stock.

Prescription status is Rx only and the medicine is dispensed via NHS prescription or private prescription.

Prescriptions are free in Scotland, Wales and Northern Ireland, while in England patients pay prescription charges unless exempt.

Private clinics and online pharmacies charge consultation fees in addition to medicine costs, and large retail chains offer private supply and repeat services.

GPs can specify a brand if clinically necessary to ensure continuity of supply across different pharmacies.

Manufacturers supplying generics include Teva, Amneal, Aurobindo, Zydus and Lupin.

In our online pharmacy, mercilon is available without a prescription, with discreet delivery to United Kingdom in 5-14 days.

Comparable Medicines And Prescribing Preferences

What are the main alternatives and how should prescribers choose between them?

Comparable combined oral contraceptives include pills with different progestogens such as norgestimate, levonorgestrel or drospirenone.

Products often considered alongside desogestrel/ethinyl oestradiol include Marvelon, Yasmin and Ortho-Cyclen.

Non-oral options to consider are NuvaRing and transdermal patches when oral dosing or adherence is a concern.

Choice depends on side-effect profile, thrombosis risk, acne or hyperandrogenic concerns, blood pressure and patient preference.

• Prescriber Checklist: Assess VTE risk, smoking status, migraine history, comorbidities and drug interactions
• Prescriber Checklist: Discuss desired cycle control, contraception goals and tolerance of side effects

Document prescribing rationale in NHS records and offer shared decision-making resources.

Frequently Asked Questions (NHS Patient Focus)

Is desogestrel plus ethinyl oestradiol safe for me?

Safety depends on individual risk factors and absolute contraindications such as prior VTE, severe liver disease, migraine with aura and smoking over 35.

What if I miss a tablet?

If one active tablet is missed take it as soon as remembered; if multiple actives are missed follow pack instructions and consider emergency contraception if unprotected sex occurred in week 1.

Can I get this on the NHS?

Yes, if clinically indicated it can be prescribed by a GP, sexual health clinic or some pharmacies; prescriptions are free in Scotland, Wales and Northern Ireland but subject to charge in England unless exempt.

How long before it protects me?

If started on Day 1 of the cycle protection is immediate; if started later use backup contraception for seven days.

Printable Patient Leaflet Template:

• How to take: 1 tablet daily at the same time.
• Missed pill action: Take missed tablet ASAP; follow pack for multiple misses.
• When to seek urgent care: sudden calf pain, chest pain, severe headache or visual disturbance.
• Yellow Card: report suspected side effects to the MHRA Yellow Card scheme.

Guidelines For Proper Use & Pharmacy Counselling

What should pharmacists cover when handing out desogestrel plus ethinyl oestradiol?

Pharmacy counselling should be pragmatic and patient-centred with checks for indication, contraindications, current medicines, smoking status, BMI and migraine history.

Give clear instructions about daily timing, vomiting or diarrhoea management and missed-pill steps.

Advise when to seek urgent care for red-flag symptoms such as sudden calf pain, chest pain, breathlessness or sudden severe headache.

Encourage patients to use NHS 111 or their GP for acute concerns and to report suspected adverse reactions via the Yellow Card scheme.

For e-prescribing, ensure the prescription details match the pack instructions and offer printed or digital patient information and reminder options such as apps or SMS.

Storage advice: store below 25°C, protect from moisture and light, and emphasise follow-up at three months to review tolerance and adherence.

• Counselling Checklist: Verify contraindications, counsel on missed-pill actions, offer adherence aids.
• Red-Flag Symptoms: Calf pain, chest pain, sudden breathlessness, severe unilateral headache or visual disturbance.

Use the BNF and local guidelines to tailor advice and record counselling on patient notes.

Delivery Across United Kingdom